Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinsonâs disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
äŒæ¥ã³ãŒãAMRX
äŒç€ŸåAmneal Pharmaceuticals Inc
äžå Žæ¥Nov 18, 2009
æé«çµå¶è²¬ä»»è
ãCEOãPatel (Chintu)
åŸæ¥å¡æ°8100
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Nov 18
æ¬ç€Ÿæåšå°400 Crossing Boulevard, 3rd Floor
éœåžBRIDGEWATER
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·08807
é»è©±çªå·19089473120
ãŠã§ããµã€ãhttps://amneal.com/
äŒæ¥ã³ãŒãAMRX
äžå Žæ¥Nov 18, 2009
æé«çµå¶è²¬ä»»è
ãCEOãPatel (Chintu)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã